Malaria burden and artemisinin resistance in the mobile and migrant population on the Thai-Myanmar border, 1999-2011: an observational study.

BACKGROUND: The Shoklo Malaria Research Unit has been working on the Thai-Myanmar border for 25 y providing early diagnosis and treatment (EDT) of malaria. Transmission of Plasmodium falciparum has declined, but resistance to artesunate has emerged. We expanded malaria activities through EDT and eva...

সম্পূর্ণ বিবরণ

গ্রন্থ-পঞ্জীর বিবরন
প্রধান লেখক: Carrara, V, Lwin, K, Phyo, A, Ashley, E, Wiladphaingern, J, Sriprawat, K, Rijken, M, Boel, M, McGready, R, Proux, S, Chu, C, Singhasivanon, P, White, N, Nosten, F
বিন্যাস: Journal article
ভাষা:English
প্রকাশিত: Public Library of Science 2013
_version_ 1826274624422281216
author Carrara, V
Lwin, K
Phyo, A
Ashley, E
Wiladphaingern, J
Sriprawat, K
Rijken, M
Boel, M
McGready, R
Proux, S
Chu, C
Singhasivanon, P
White, N
Nosten, F
author_facet Carrara, V
Lwin, K
Phyo, A
Ashley, E
Wiladphaingern, J
Sriprawat, K
Rijken, M
Boel, M
McGready, R
Proux, S
Chu, C
Singhasivanon, P
White, N
Nosten, F
author_sort Carrara, V
collection OXFORD
description BACKGROUND: The Shoklo Malaria Research Unit has been working on the Thai-Myanmar border for 25 y providing early diagnosis and treatment (EDT) of malaria. Transmission of Plasmodium falciparum has declined, but resistance to artesunate has emerged. We expanded malaria activities through EDT and evaluated the impact over a 12-y period. METHODS AND FINDINGS: Between 1 October 1999 and 30 September 2011, the Shoklo Malaria Research Unit increased the number of cross-border (Myanmar side) health facilities from two to 11 and recorded the number of malaria consultations. Changes in malaria incidence were estimated from a cohort of pregnant women, and prevalence from cross-sectional surveys. In vivo and in vitro antimalarial drug efficacy were monitored. Over this period, the number of malaria cases detected increased initially, but then declined rapidly. In children under 5 y, the percentage of consultations due to malaria declined from 78% (95% CI 76-80) (1,048/1,344 consultations) to 7% (95% CI 6.2-7.1) (767/11,542 consultations), p<0.001. The ratio of P. falciparum/P. vivax declined from 1.4 (95% CI 1.3-1.4) to 0.7 (95% CI 0.7-0.8). The case fatality rate was low (39/75,126; 0.05% [95% CI 0.04-0.07]). The incidence of malaria declined from 1.1 to 0.1 episodes per pregnant women-year. The cumulative proportion of P. falciparum decreased significantly from 24.3% (95% CI 21.0-28.0) (143/588 pregnant women) to 3.4% (95% CI 2.8-4.3) (76/2,207 pregnant women), p<0.001. The in vivo efficacy of mefloquine-artesunate declined steadily, with a sharp drop in 2011 (day-42 PCR-adjusted cure rate 42% [95% CI 20-62]). The proportion of patients still slide positive for malaria at day 3 rose from 0% in 2000 to reach 28% (95% CI 13-45) (8/29 patients) in 2011. CONCLUSIONS: Despite the emergence of resistance to artesunate in P. falciparum, the strategy of EDT with artemisinin-based combination treatments has been associated with a reduction in malaria in the migrant population living on the Thai-Myanmar border. Although limited by its observational nature, this study provides useful data on malaria burden in a strategically crucial geographical area. Alternative fixed combination treatments are needed urgently to replace the failing first-line regimen of mefloquine and artesunate. Please see later in the article for the Editors' Summary.
first_indexed 2024-03-06T22:46:17Z
format Journal article
id oxford-uuid:5d498eb1-cfa6-436e-910e-80cca81f28e7
institution University of Oxford
language English
last_indexed 2024-03-06T22:46:17Z
publishDate 2013
publisher Public Library of Science
record_format dspace
spelling oxford-uuid:5d498eb1-cfa6-436e-910e-80cca81f28e72022-03-26T17:33:29ZMalaria burden and artemisinin resistance in the mobile and migrant population on the Thai-Myanmar border, 1999-2011: an observational study.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:5d498eb1-cfa6-436e-910e-80cca81f28e7EnglishSymplectic Elements at OxfordPublic Library of Science2013Carrara, VLwin, KPhyo, AAshley, EWiladphaingern, JSriprawat, KRijken, MBoel, MMcGready, RProux, SChu, CSinghasivanon, PWhite, NNosten, FBACKGROUND: The Shoklo Malaria Research Unit has been working on the Thai-Myanmar border for 25 y providing early diagnosis and treatment (EDT) of malaria. Transmission of Plasmodium falciparum has declined, but resistance to artesunate has emerged. We expanded malaria activities through EDT and evaluated the impact over a 12-y period. METHODS AND FINDINGS: Between 1 October 1999 and 30 September 2011, the Shoklo Malaria Research Unit increased the number of cross-border (Myanmar side) health facilities from two to 11 and recorded the number of malaria consultations. Changes in malaria incidence were estimated from a cohort of pregnant women, and prevalence from cross-sectional surveys. In vivo and in vitro antimalarial drug efficacy were monitored. Over this period, the number of malaria cases detected increased initially, but then declined rapidly. In children under 5 y, the percentage of consultations due to malaria declined from 78% (95% CI 76-80) (1,048/1,344 consultations) to 7% (95% CI 6.2-7.1) (767/11,542 consultations), p<0.001. The ratio of P. falciparum/P. vivax declined from 1.4 (95% CI 1.3-1.4) to 0.7 (95% CI 0.7-0.8). The case fatality rate was low (39/75,126; 0.05% [95% CI 0.04-0.07]). The incidence of malaria declined from 1.1 to 0.1 episodes per pregnant women-year. The cumulative proportion of P. falciparum decreased significantly from 24.3% (95% CI 21.0-28.0) (143/588 pregnant women) to 3.4% (95% CI 2.8-4.3) (76/2,207 pregnant women), p<0.001. The in vivo efficacy of mefloquine-artesunate declined steadily, with a sharp drop in 2011 (day-42 PCR-adjusted cure rate 42% [95% CI 20-62]). The proportion of patients still slide positive for malaria at day 3 rose from 0% in 2000 to reach 28% (95% CI 13-45) (8/29 patients) in 2011. CONCLUSIONS: Despite the emergence of resistance to artesunate in P. falciparum, the strategy of EDT with artemisinin-based combination treatments has been associated with a reduction in malaria in the migrant population living on the Thai-Myanmar border. Although limited by its observational nature, this study provides useful data on malaria burden in a strategically crucial geographical area. Alternative fixed combination treatments are needed urgently to replace the failing first-line regimen of mefloquine and artesunate. Please see later in the article for the Editors' Summary.
spellingShingle Carrara, V
Lwin, K
Phyo, A
Ashley, E
Wiladphaingern, J
Sriprawat, K
Rijken, M
Boel, M
McGready, R
Proux, S
Chu, C
Singhasivanon, P
White, N
Nosten, F
Malaria burden and artemisinin resistance in the mobile and migrant population on the Thai-Myanmar border, 1999-2011: an observational study.
title Malaria burden and artemisinin resistance in the mobile and migrant population on the Thai-Myanmar border, 1999-2011: an observational study.
title_full Malaria burden and artemisinin resistance in the mobile and migrant population on the Thai-Myanmar border, 1999-2011: an observational study.
title_fullStr Malaria burden and artemisinin resistance in the mobile and migrant population on the Thai-Myanmar border, 1999-2011: an observational study.
title_full_unstemmed Malaria burden and artemisinin resistance in the mobile and migrant population on the Thai-Myanmar border, 1999-2011: an observational study.
title_short Malaria burden and artemisinin resistance in the mobile and migrant population on the Thai-Myanmar border, 1999-2011: an observational study.
title_sort malaria burden and artemisinin resistance in the mobile and migrant population on the thai myanmar border 1999 2011 an observational study
work_keys_str_mv AT carrarav malariaburdenandartemisininresistanceinthemobileandmigrantpopulationonthethaimyanmarborder19992011anobservationalstudy
AT lwink malariaburdenandartemisininresistanceinthemobileandmigrantpopulationonthethaimyanmarborder19992011anobservationalstudy
AT phyoa malariaburdenandartemisininresistanceinthemobileandmigrantpopulationonthethaimyanmarborder19992011anobservationalstudy
AT ashleye malariaburdenandartemisininresistanceinthemobileandmigrantpopulationonthethaimyanmarborder19992011anobservationalstudy
AT wiladphaingernj malariaburdenandartemisininresistanceinthemobileandmigrantpopulationonthethaimyanmarborder19992011anobservationalstudy
AT sriprawatk malariaburdenandartemisininresistanceinthemobileandmigrantpopulationonthethaimyanmarborder19992011anobservationalstudy
AT rijkenm malariaburdenandartemisininresistanceinthemobileandmigrantpopulationonthethaimyanmarborder19992011anobservationalstudy
AT boelm malariaburdenandartemisininresistanceinthemobileandmigrantpopulationonthethaimyanmarborder19992011anobservationalstudy
AT mcgreadyr malariaburdenandartemisininresistanceinthemobileandmigrantpopulationonthethaimyanmarborder19992011anobservationalstudy
AT prouxs malariaburdenandartemisininresistanceinthemobileandmigrantpopulationonthethaimyanmarborder19992011anobservationalstudy
AT chuc malariaburdenandartemisininresistanceinthemobileandmigrantpopulationonthethaimyanmarborder19992011anobservationalstudy
AT singhasivanonp malariaburdenandartemisininresistanceinthemobileandmigrantpopulationonthethaimyanmarborder19992011anobservationalstudy
AT whiten malariaburdenandartemisininresistanceinthemobileandmigrantpopulationonthethaimyanmarborder19992011anobservationalstudy
AT nostenf malariaburdenandartemisininresistanceinthemobileandmigrantpopulationonthethaimyanmarborder19992011anobservationalstudy